FRA:GIS • US3755581036
This GIS.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
Taking everything into account, GIS scores 7 out of 10 in our fundamental rating. GIS was compared to 75 industry peers in the Biotechnology industry. GIS gets an excellent profitability rating and is at the same time showing great financial health properties. GIS has a decent growth rate and is not valued too expensively. With these ratings, GIS could be worth investigating further for quality investing!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 14.42% | ||
| ROE | 37.49% | ||
| ROIC | 19.49% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 39.98% | ||
| PM (TTM) | 28.9% | ||
| GM | 78.83% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.97 | ||
| Debt/FCF | 2.64 | ||
| Altman-Z | 4.65 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.55 | ||
| Quick Ratio | 1.4 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.21 | ||
| Fwd PE | 16.64 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 19.48 | ||
| EV/EBITDA | 13.61 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.28% |
FRA:GIS (3/5/2026, 10:50:57 AM)
127.44
+0.46 (+0.36%)
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.28% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.21 | ||
| Fwd PE | 16.64 | ||
| P/S | 6.26 | ||
| P/FCF | 19.48 | ||
| P/OCF | 18.39 | ||
| P/B | 8.11 | ||
| P/tB | N/A | ||
| EV/EBITDA | 13.61 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 14.42% | ||
| ROE | 37.49% | ||
| ROCE | 24.94% | ||
| ROIC | 19.49% | ||
| ROICexc | 25.18% | ||
| ROICexgc | 81.81% | ||
| OM | 39.98% | ||
| PM (TTM) | 28.9% | ||
| GM | 78.83% | ||
| FCFM | 32.11% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.97 | ||
| Debt/FCF | 2.64 | ||
| Debt/EBITDA | 1.52 | ||
| Cap/Depr | 20.4% | ||
| Cap/Sales | 1.91% | ||
| Interest Coverage | 11.36 | ||
| Cash Conversion | 68.94% | ||
| Profit Quality | 111.11% | ||
| Current Ratio | 1.55 | ||
| Quick Ratio | 1.4 | ||
| Altman-Z | 4.65 |
ChartMill assigns a fundamental rating of 7 / 10 to GIS.DE.
ChartMill assigns a valuation rating of 6 / 10 to GILEAD SCIENCES INC (GIS.DE). This can be considered as Fairly Valued.
GILEAD SCIENCES INC (GIS.DE) has a profitability rating of 9 / 10.
The financial health rating of GILEAD SCIENCES INC (GIS.DE) is 8 / 10.
The Earnings per Share (EPS) of GILEAD SCIENCES INC (GIS.DE) is expected to grow by 9.44% in the next year.